Robert Fischer, MD
MOHS-Micrographic Surgery · Tulsa, OKNPI 1023378759
Payments from drug & device makers
Across 468 payments — averaging $22.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Kerecis Limited$2K
- Regeneron Healthcare Solutions, Inc.$829
- Johnson & Johnson$699
- Novartis$650
- Amgen$565
- plus $4K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 127 | $2,327 |
| Kerecis Limited | 3 | $1,714 |
| Regeneron Healthcare Solutions, Inc. | 31 | $829 |
| Johnson & Johnson | 32 | $699 |
| Novartis | 40 | $650 |
| Amgen | 18 | $565 |
| Sun Pharmaceutical Industries Inc. | 22 | $478 |
| UCB, Inc. | 33 | $462 |
| Lilly USA, LLC | 26 | $412 |
| LEO Pharma Inc. | 14 | $275 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 13 | $264 |
| Dermavant Sciences, Inc. | 8 | $219 |
| Organogenesis Inc. | 8 | $211 |
| VYNE Pharmaceuticals Inc. | 10 | $202 |
| Mayne Pharma Commercial LLC | 12 | $202 |
| Galderma Laboratories, L.p. | 12 | $179 |
| Pfizer | 10 | $179 |
| Sanofi | 7 | $146 |
| Incyte Corporation | 6 | $109 |
| Genentech USA, Inc. | 7 | $105 |
| Prugen, Inc. Pharmaceuticals | 6 | $96 |
| Dermira, Inc. | 4 | $76 |
| Almirall LLC | 3 | $50 |
| Strata Skin Sciences, Inc. | 4 | $47 |
| Organon | 3 | $26 |
| Celltrion USA Inc. | 1 | $24 |
| Mylan Pharmaceuticals Inc. | 1 | $22 |
| Bristol Myers Squibb | 1 | $20 |
| Sebela Pharmaceuticals Inc. | 1 | $18 |
| Sandoz | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Aclaris Therapeutics, Inc. | 1 | $16 |
| Conmed Corporation | 1 | $15 |
| Promius Pharma LLC | 1 | $15 |
How this compares
Too few mohs-micrographic surgery providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other mohs-micrographic surgery in Tulsa
- Mary Christian ReedTulsa$13K
- Edward YobTulsa$380
- Scott MeyersTulsa$307
- Carlos GarciaOklahoma City$14K
- Travis BlalockOklahoma City$13K
- Carlos Gomez-MeadeBroken Arrow$2K
- Jason HirshburgOklahoma City$1K
- Todd MolletOklahoma City$808
- James StewartOklahoma City$784
- Brandon RhinehartOklahoma City$620
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.